SuperworthFirefly Neuroscience AIFF
- Market cap
- $14.4M
- PE
- n/m
- one or more of the four quarters through 2026-06-30 missing
- Forward PE
- n/m
- not a meaningful number
- Price to sales
- 8.0×
- EV/EBIT
- n/m
- a loss over the last year
- Revenue, 12 months
- $1.8M
- growth n/m, growth from a base too small to compare
- Net margin
- n/m
- outside −100% to 100%
- Free cash flow yield
- n/m
- not a meaningful number
Firefly Neuroscience trades at 8.0× sales. Revenue was $1.8M over the last twelve months.
Charts
Financials
| Income statement | Q3 FY23 | Q4 FY23 | Q1 FY24 | Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $23K−99% | $1.8M−7% | $12K−99% | $10K−100% | $33K+44% | $53K−97% | $43K+258% | $299K+2890% | $388K+1076% | $412K+677% | $485K+1028% | $514K+72% | |
| Cost of revenue | $1.3M−16% | $1.2M−15% | $1.2M−19% | $0 | n/a | n/a | $0 | $25K | $242K | $230K | $264K | $261K+944% |
| Gross profit | $649.8K−12% | $602.7K+15% | $699.3K+7% | $10K−99% | $33K−95% | $53K−91% | $43K−94% | $274K+2640% | $146K+342% | $182K+243% | $221K+414% | $253K−8% |
| R&D | $392K | $29K | $289K | $350K | $878K+124% | $437K+1407% | $312K+8% | $336K−4% | $378K−57% | $456K+4% | $424K+36% | $525K+56% |
| SG&A | $278K−85% | $1.4M−8% | $814K−50% | $919K−44% | $3.4M+1131% | $2.2M+55% | $1.8M+121% | $1.6M+71% | $2.3M−34% | $2.1M−2% | $1.8M+1% | $1.7M+8% |
| −$647K−43% | −$1.6M+55% | −$1.1M+14% | −$1.3M | −$4.3M+560% | −$3.4M+119% | −$2.1M+89% | −$1.6M+30% | −$2.7M−38% | −$2.5M−27% | −$2M−3% | −$2M+21% | |
| Interest expense | $18.7K−8% | $12.3K−44% | $10.7K−70% | $10.4K−72% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Pre-tax income | −$650K−43% | −$1.1M+4% | −$1.1M+13% | −$1.3M | −$4.3M+560% | −$3.8M+252% | −$12.9M+1052% | −$1.8M+45% | −$2.6M−39% | −$2.5M−35% | −$2M−85% | −$2M+9% |
| $0 | $1K−96% | $0 | $0 | $0 | $2K+100% | $0 | $4K | $0 | $1K−50% | $0 | $0 | |
| Net income | −$650K−86% | −$1.1M−89% | −$1.1M−17% | −$1.3M | −$4.3M+560% | −$3.8M+251% | −$12.9M+1052% | −$1.8M+45% | −$2.6M−39% | −$2.5M−35% | −$2M−85% | −$2M+8% |
| n/a | n/a | n/a | $0.00 | −$0.61 | n/a | n/a | n/a | −$0.20−67% | n/a | n/a | n/a | |
| n/a | n/a | n/a | 671.1K+4% | 7.1M | n/a | n/a | n/a | 13.5M+91% | n/a | n/a | n/a |
EPS, diluted: 14 periods, Q4 FY10 to Q2 FY24: quarter's net income to common over its shares, to the cent.
Diluted shares: 5 periods, Q4 FY10 to Q4 FY21: a loss quarter: its basic count, share-days: the 12-month average less the 9-month, weighted by days. 6 periods, Q4 FY11 to Q4 FY20: share-days: the 12-month average less the 9-month, weighted by days. Q4 FY15: the earlier year to date counted no dilution: the quarter's basic count plus the later year to date's dilution.
From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet.
Peers
Companies in Software - Infrastructure nearest Firefly Neuroscience's size, closest first.
| Company | Market cap | PE | Its 10y median PE | Fwd PE | P/S | Revenue growth | Net margin |
|---|---|---|---|---|---|---|---|
| AIFFFirefly Neuroscience | $14.4M | n/m | 117× | 8.0× | n/m | n/m | |
| MSGMMotorsport Games | $22.5M | 11.4× | 11.5× | 1.5× | +79% | 16.2% | |
| FIEEFiEE | $26.9M | 9.3× | 102× | n/m | n/m | n/m | |
| IDNIntellicheck | $49.5M | 16.3× | 39.8× | 2.1× | +17% | 13.0% | |
| WFCFWhere Food Comes From | $74.6M | 53.5× | 42.3× | 3.0× | −2% | 5.8% | |
| CCLDCareCloud | $75.2M | 25.3× | 37.4× | 0.6× | +15% | 6.2% | |
| FATNFatpipe | $75.3M | 13.7× | 17.2× | 3.7× | +23% | n/m | |
| NTWKNetsol Technologies | $93.9M | 31.4× | 22.2× | 1.3× | +13% | 4.0% | |
| Peer median | $74.6M | 16.3× | 37.4× | 1.8× | +16% | 6.2% |
More on Firefly Neuroscience
Each number over time
- PE ratio
- Price to sales ratio
- EV/EBIT
- Price to free cash flow
- Price to book ratio
- Market cap
- Revenue
- EPS
- Free cash flow
- Profit margin
- Shares outstanding
Its groups
About
- Industry
- Software - Infrastructure
- Sector
- Technology
Valuation data, not investment advice. Prices as of .